PReS-FINAL-2100: Methotrexate treatment affects effector, but not regulatory T cells in juvenile idiopathic arthritis

por Vastert, S, Bulatovic-Calasan, M, Scholman, R, Klein, M, Wulffraat, N, Prakken, B, Wijk, FV
Publicado 2013

PReS-FINAL-2162: Development of a risk model to predict methotrexate intolerance in juvenile idiopathic arthritis

por Van Dijkhuizen, P, Bulatovic-Calasan, M, Pluijm, S, De Rotte, M, Vastert, B, Kamphuis, S, De Jonge, R, Wulffraat, N
Publicado 2013

Subcutaneous administration, higher age and lower renal function are associated with erythrocyte methotrexate accumulation in Crohn’s disease: a cross-sectional study

por van de Meeberg, M. M., Seinen, M. L., Fidder, H. H., Lin, M., Oldenburg, B., de Boer, N. K., Bouma, G., de Jonge, R., Bulatović Ćalasan, M.
Publicado 2022